Akari Therapeutics, Plc
AKTX
$1.46
$0.0070.48%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/22/2025
-
GuruFocus
4/22/2025
-
GuruFocus
4/22/2025
-
GuruFocus
4/22/2025
-
The Fly
4/22/2025
-
Globe Newswire
4/16/2025
-
SeekingAlpha.com: All News
4/16/2025
-
GuruFocus
4/16/2025
-
GuruFocus
4/16/2025
-
GuruFocus
4/16/2025
-
The Fly
4/16/2025
-
Globe Newswire
4/14/2025
-
Ticker Report
3/21/2025
-
Ticker Report
3/20/2025
-
GuruFocus
3/20/2025
-
Seeking Alpha - Healthcare
3/20/2025
-
TipRanks Financial Blog
3/20/2025
-
The Fly
3/20/2025
-
Globe Newswire
3/13/2025
-
Zolmax
3/3/2025
-
TipRanks Financial Blog
3/3/2025
-
The Fly
3/3/2025
-
GuruFocus
3/3/2025
-
Globe Newswire
2/22/2025
-
Ticker Report
2/19/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, April 15, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
929 274 7510
Address
22 Boston Wharf Road
Boston, MA 02210
Boston, MA 02210
Country
Year Founded
--
Business Description
Sector
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a...
more